Free lookups: 2/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
2 of 3 free lookups remaining Upgrade
New search Medicine profile Vitamin B6 (Pyridoxine)

Clinical medicine profile

Vitamin B6 (Pyridoxine)

Vitamin / mineral / nutritional supplement

POM
Evidence state Source not available Reviewed 14 Aug 2026
Route
ORAL / IM / IV (selected)
Schedule
POM
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
Verification required

This profile needs source confirmation

A traceable source link is not attached to this profile. Confirm prescribing decisions against the current SmPC and Kenya STG/EML.

01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • Hypervitaminosis risk states (hypercalcaemia for vitamin D/A).
  • Iron: avoid in iron overload.
  • Potassium: severe hyperkalaemia / untreated Addison's.

Precautions

  • Treat confirmed deficiency with monitored repletion.
  • Avoid megadoses without indication.
  • Iron: keep away from children (overdose lethal).
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

Deficiency states: 20-50mg TID. Isoniazid neuropathy prophylaxis -100mg OD.

Paediatric

See label paediatric section if present; otherwise use paediatric formulary — do not extrapolate adult doses.

Renal

Fat-soluble vitamins and potassium need care in advanced CKD.

  • CrCl 0–120: Confirm renal dosing in product SmPC / primary label.
Hepatic

Vitamin A toxicity hepatic; niacin hepatotoxicity at high dose.

03 Clinical use

Use, effects & interactions

Indications

  • Treatment of isoniazid toxicity
  • treatment cycloserine toxicity
  • hereditary pyridoxine dependency syndrome by neonates
  • prophylaxis and treatment of pyridoxine deficiency
  • conditions in which supplementation is required include alcoholism, burns
  • chronic fever, gastrectomy, haemodialysis, diarrhoea, prolonged stress among others.

Adverse effects

  • GI upset (iron, high-dose vitamin C).
  • Hypercalcaemia (vitamin D excess).
  • Neuropathy with B6 megadoses.
  • Flushing (niacin).
  • ||| Deficiency symptoms may be seen during isoniazid therapy and include: sideroblastic anaemia and xanthurenic aciduria
  • neurologic problems [It is characterized by peripheral neuritis]
  • cheilosis
  • seborrheic dermatitis.
04 Pharmacology

Mechanism & disposition

It is converted [in erythrocytes] to pyridoxal phosphate and pyridoxamine phos- phate.

It is converted [in erythrocytes] to pyrid…These act as coenzymes for various meta- b…Its use as an antidote is due to the fact…
Read complete mechanism

It is converted [in erythrocytes] to pyridoxal phosphate and pyridoxamine phos- phate. These act as coenzymes for various meta- bolic functions involving protein, carbohydrate, and lipid utilization. Its use as an antidote is due to the fact that it increases the excretion of certain drugs like cycloserine and isoniazid, which act as its antag- onists.

Onset

Days–weeks for repletion

Duration

Depends on stores and ongoing intake

Route

ORAL / IM / IV (selected)

Absorption

depends on GI integrity, food matrix and binders (e.g. calcium/iron interactions). Fat-soluble vitamins (A,D,E,K) accumulate; water-soluble generally renally cleared.

05 Special populations

Pregnancy, lactation & diet

Pregnancy

Folic acid preconception/first trimester critical. Iron/folate common in ANC. Avoid excess vitamin A.

Lactation

Maternal repletion often appropriate; avoid megadoses.

06 Kenya market

Brands & loaded prices

From
Median
Listings0
BrandManufacturerPackObserved price
No reviewed brand listings are linked yet.
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; Professional class pharmacology (Vitamin / mineral / nutritional supplement)
Last reviewed14 Aug 2026
EvidenceSource not available

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.